Virtu KCG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-11,900
Closed -$1M 3286
2015
Q4
$1M Sell
11,900
-5,100
-30% -$423K 0.02% 847
2015
Q3
$1.42M Buy
17,000
+10,600
+166% +$895K 0.02% 629
2015
Q2
$534K Buy
6,400
+900
+16% +$68.6K 0.01% 1427
2015
Q1
$400K Sell
5,500
-18,500
-77% -$1.32M 0.01% 1594
2014
Q4
$1.66M Sell
24,000
-1,300
-5% -$87.7K 0.03% 535
2014
Q3
$1.64M Sell
25,300
-6,400
-20% -$405K 0.03% 596
2014
Q2
$1.97M Sell
31,700
-4,200
-12% -$251K 0.03% 554
2014
Q1
$2.11M Sell
35,900
-4,300
-11% -$240K 0.03% 649
2013
Q4
$2.05M Buy
40,200
+1,700
+4% +$85.1K 0.02% 653
2013
Q3
$1.94M Buy
+38,500
New +$2.02M 0.02% 647

Other funds holding LLY

Virtu KCG Holdings's LLY Position: Q2 2017 in Review

Virtu KCG Holdings increased its Eli Lilly (LLY) stake by 263% in Q2 2017, buying an estimated $2.46M and bringing the position to 41,582 shares worth $3.42M. The position accounts for 0.1% of the portfolio, ranked #109.

Virtu KCG Holdings first reported a position in LLY in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.32M in Q1 2015. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Virtu KCG Holdings held 41,582 shares of Eli Lilly worth $3.42M as of Q2 2017.
  • Virtu KCG Holdings bought 30,114 Eli Lilly shares in Q2 2017, an estimated $2.46M.
  • Eli Lilly made up 0.1% of Virtu KCG Holdings's portfolio in Q2 2017, its #109 holding.
  • Virtu KCG Holdings first reported a position in Eli Lilly in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Eli Lilly position peaked at $5.32M in Q1 2015.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.